News

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

Grant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools to enable healthcare professionals with…

7 months ago

Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced…

7 months ago

Three Amwell® Health System Clients to Lead Hybrid Care Panel at Oracle Health Conference

Leaders from Aultman Health, Banner Health and Children’s National Hospital to share successes with Amwell platforms and Oracle Health integrationBOSTON--(BUSINESS…

7 months ago

Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction

Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that…

7 months ago

FloraWorks Announces Updated Analysis of Landmark Clinical Trial; CBN Shown Effective for Sleep

Radicle Science found TruCBN(TM) to significantly improve sleep outcomes in first-ever placebo-controlled trial of pure CBNPortland, Oregon--(Newsfile Corp. - September…

7 months ago

iTolerance, Inc. Bolsters Global Intellectual Property with Issuance of European Patent for Proprietary Regenerative SA-FasL Microgel Technology, iTOL-100

Company leveraging iTOL-100 to advance a pipeline of programs that have the potential to cure diseases, such as Type 1…

7 months ago

Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

7 months ago

Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier

Interventional study compares VitaGraft to current transplant rejection monitoring protocolsOncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than…

7 months ago

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated

TORONTO, ON / ACCESSWIRE / September 18, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

7 months ago

TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing…

7 months ago